Pharmacists’ Patient Care Process: State “Scope of Practice” Priorities for Action

Abstract

To fully engage in the Pharmacists’ Patient Care Process, pharmacists must be able to (1) participate in a Collaborative Practice Agreement, (2) order and interpret laboratory tests, (3) prescribe certain medications, (4) adapt medications, (5) administer medications, and (6) effectively delegate tasks to support staff. Each of these activities is dependent on state scope of practice laws, but these laws are not binary. Various state-level restrictions allow us to view these activities on a continuum from more restrictive to less restrictive. This continuum will allow pharmacy and public health stakeholders to identify priorities for action in their states.

Keywords

law legal/regulatory issues pharmaceutical care clinical pharmacy

Get full access to this article

View all access options for this article.

References

Adams

Weaver

KK.

Pharmacists’ Patient Care Process: a state “scope of practice” perspective. Innov Pharm. 2019;10(2). doi:10.24926/iip.v10i2.1389

National Alliance of State Pharmacy Associations. Pharmacist Collaborative Practice Agreements: key elements for legislative and regulatory authority. Accessed July 4, 2020. https://naspa.us/wp-content/uploads/2017/01/CPA-Workgroup-Report-FINAL.pdf

National Alliance of State Pharmacy Associations; National Association of Boards of Pharmacy. Pharmacist statewide protocols: key elements for legislative and regulatory authority. Accessed July 4, 2020. https://naspa.us/wp-content/uploads/2017/03/Pharmacist-Statewide-Protocols-Key-Elements-for-Legislative-and-Regulatory-Authority.pdf

National Alliance of State Pharmacy Associations; College of Psychiatric and Neurologic Pharmacists. State policy recommendations for pharmacist administration of medications. Accessed July 4, 2020. https://naspa.us/wp-content/uploads/2017/04/Medication-Administration-Meeting-Report-FINAL.pdf

Centers for Disease Control and Prevention. Advancing team-based care through Collaborative Practice Agreements: a resource and implementation guide for adding pharmacists to the care team. Accessed July 4, 2020. https://www.cdc.gov/dhdsp/pubs/docs/CPA-Team-Based-Care.pdf

Bacci

Coley

McGrath

, et al. Strategies to facilitate the implementation of Collaborative Practice Agreements in chain community pharmacies. J Am Pharm Assoc (2003). 2016;56:257-265.e2. doi:10.1016/j.japh.2016.02.014

Wisconsin State Legislature. 2013 Wisconsin Act 294. Published April 17, 2014. Accessed July 4, 2020. https://docs.legis.wisconsin.gov/2013/related/acts/294

Texas Administrative Code. Title 22, Part 15, Chapter 295, Rule 295.13. Drug therapy management by a pharmacist under written protocol of a physician. Accessed July 4, 2020. https://casetext.com/regulation/texas-administrative-code/title-22-examining-boards/part-15-texas-state-board-of-pharmacy/chapter-295-pharmacists/section-29513-drug-therapy-management-by-a-pharmacist-under-written-protocol-of-a-physician

Frost

Adams

AJ.

Are advanced practice pharmacist designations really advanced?

Res Social Adm Pharm. 2018;14:501-504. doi:10.1016/j.sapharm.2017.10.002

10.

Adams

Weaver

KK.

The continuum of pharmacist prescriptive authority. Ann Pharmacother. 2016;50:778-784.

11.

Pennsylvania Code & Bulletin. §27.302. Collaborative agreement for management of drug therapy in a non-institutional setting. Accessed July 4, 2020. http://www.pacodeandbulletin.gov/home/Pacode?query=27.302&pageNumber=1&location=Pacode&contents=&customDataFilters=%5B%5D&sortBy=null

12.

West Virginia Secretary of State. Administrative Law. Collaborative Pharmacy Practice. Accessed July 4, 2020. http://apps.sos.wv.gov/adlaw/csr/ruleview.aspx?document=5713

13.

North Dakota Board of Pharmacy. Chapter 61-04-10: CLIA waived laboratory tests. Accessed July 4, 2020. https://www.nodakpharmacy.com/pdfs/61-04-10.pdf

14.

Pennsylvania Code. Chapter 5: Clinical laboratories. Accessed July 4, 2020. http://www.pacode.com/secure/data/028/chapter5/chap5toc.html

15.

Klepser

Adams

Srnis

Mazzucco

Klepser

US community pharmacies as CLIA-waived facilities: prevalence, dispersion, and impact of access to testing. Res Social Adm Pharm. 2016;12:614-621. doi:10.1016/j.sagepharm.2015.09.00

16.

Adams

Klepser

An update on community pharmacies as CLIA-waived facilities. Res Social Adm Pharm. 2016;12:666-667. doi:10.1016/j.sapharm.2016.03.007

17.

Weber

Klepser

Akers

Klepser

Adams

AJ.

Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States. Expert Rev Mol Diagn. 2016;16:253-264. doi:10.1586/14737159.2015.1116388

18.

Adams

Dering-Anderson

Pharmacy-based travel health services: state approaches to prescriptive authority. J Pharm Technol. 2018;34:175-180. doi:10.1177/8755122518770465

19.

Adams

Hudmon

KS.

Pharmacist prescriptive authority for tobacco cessation medications. J Am Pharm Assoc (2003). 2018;58:253-257. doi:10.1016/j.japh.2017.12.015

20.

Adams

AJ.

Pharmacist prescriptive authority for epinephrine auto-injectors in Idaho. Innov Pharm. 2016;7:14.

21.

Klepser

Adams

AJ.

Pharmacy-based management of influenza: lessons learned from research. Int J Pharm Pract. 2018;26:573-578. doi:10.1111/ijpp.12488

22.

Dering-Anderson

Adams

AJ.

Improving access to appropriate post-exposure doxycycline for Lyme disease prophylaxis: role for community pharmacies. J Antimicrob Chemother. 2018;73:3219-3220. doi:10.1093/jac/dky361

23.

Oregon Legislative Assembly. House Bill 2397. Accessed July 4, 2020. https://olis.leg.state.or.us/liz/2017R1/Downloads/MeasureDocument/HB2397

24.

Adams

AJ.

Pharmacist prescriptive authority: lessons from Idaho. Pharmacy (Basel). 2020;8:E112. doi:10.3390/pharmacy8030112

25.

Taylor

Joubert

Pharmacist-led minor ailment programs: a Canadian perspective. Int J Gen Med. 2016;9:291-302. doi:10.2147/IJGM.S99540

26.

Akers

Adams

Klepser

ME.

Review of pharmacy-based management of uncomplicated urinary tract infections (UTIs) in community pharmacy settings. Int J Pharm. 2018;8:63-69. Accessed June 2, 2020. http://pharmascholars.com/abstractview/review-of-pharmacy-based-management-of-uncomplicated-urinary-tract-infections-utis-in-community-pharmacy-settings

27.

Vanderholm

Renner

Stolpe

Adams

. An innovative approach to improving the proposed CMS star rating “statin use in persons with diabetes.” J Manag Care Spec Pharm. 2018;24:1126-1129. doi:10.18553/jmcp.2018.24.11.1126

28.

Oregon State Legislature. 2015 HB 2879. Accessed July 4, 2020. https://olis.leg.state.or.us/liz/2015R1/Downloads/MeasureDocument/HB2879/Enrolled

29.

Oregon Board of Pharmacy. Standard procedures algorithm for prescribing of contraceptives. Accessed July 4, 2020. https://www.oregon.gov/pharmacy/Pages/Contraceptive-Prescribing.aspx

30.

Adams

AJ.

Transitioning pharmacy to “standard of care” regulation: analyzing how pharmacy regulates relative to medicine and nursing. Res Social Adm Pharm. 2019;15:1230-1235. doi:10.1016/j.sapharm.2018.10.008

31.

Adams

AJ.

Prescription adaptation services: a regulatory and practice perspective. Ann Pharmacother. 2018;52:700-703. doi:10.1177/1060028018763883

32.

Adams

AJ.

Medication synchronization: a regulatory approach to “short fills.” J Am Pharm Assoc (2003). 2017;57:299-300.

33.

Ohio Laws and Rules. Ohio Revised Code. 4729.281 Conditions for refill of prescription. Accessed July 4, 2020. http://codes.ohio.gov/orc/4729.281

34.

Vanderholm

Klepser

Adams

AJ.

State approaches to therapeutic interchange in community pharmacy settings: legislative and regulatory authority. J Manag Care Spec Pharm. 2018;24:1260-1263.

35.

Arkansas Code. 07-00-0010-Therapeutic substitution. Accessed July 4, 2020. https://www.sos.arkansas.gov/uploads/rulesRegs/Arkansas%20Register/2014/dec2014/070.00.14-006.pdf

36.

Idaho Administrative Code. Rules governing pharmacy practice. Accessed July 4, 2020. https://adminrules.idaho.gov/rules/current/24/243601.pdf

37.

Rosenfeld

Etkind

Grasso

Adams

Rothholz

MC.

Extending the reach: local health department collaboration with community pharmacies in Palm Beach County, Florida for H1N1 influenza pandemic response. J Public Health Manag Pract. 2011;17:439-448.

38.

Ohio Laws and Rules. Ohio Revised Code. 4729.45 Administration of injections. Accessed July 4, 2020. http://codes.ohio.gov/orc/4729.45

39.

Oklahoma Board of Pharmacy. 353.30—Use of agreements—training requirements and administration of immunizations and therapeutic injections. Accessed July 4, 2020. https://law.justia.com/codes/oklahoma/2014/title-59/section-59-353.30

40.

Louisiana Administrative Code. Title 46—Professional and occupational standards. Part LIII: Pharmacists. Section 521. Prescription orders to administer medications. Accessed July 4, 2020. http://www.pharmacy.la.gov/assets/docs/pharmacist/521MedicationAdministration.pdf

41.

Adams

Martin

Stolpe

SF.

“Tech-check-tech”: a review of the evidence on its safety and benefits. Am J Health Syst Pharm. 2011;68:1824-1833.

42.

Frost

Adams

AJ.

Tech-check-tech in community pharmacy practice settings. J Pharm Technol. 2017;33:47-52. doi:10.1177/8755122516683519

43.

Frost

Adams

AJ.

Pharmacist and technician perceptions of tech-check-tech in community pharmacy practice settings. J Pharm Pract. 2018;31:190-194. doi:10.1177/0897190017703505

44.

Frost

Adams

AJ.

Expanded pharmacy technician roles: accepting verbal prescriptions and communicating prescription transfers. Res Social Adm Pharm. 2017;13:1191-1195. doi:10.1016/j.sapharm.2016.11.010

45.

Bright

Adams

AJ.

Pharmacy technician-administered immunizations in Idaho. Am J Health Syst Pharm. 2017;74:2033-2034.

46.

Atkinson

Adams

Bright

Should pharmacy technicians administer immunizations?

Innov Pharm. 2017;8:16. doi:10.24926/iip.v8i3.541

47.

Adams

Desselle

McKeirnan

KC.

Pharmacy technician-administered vaccines: on perceptions and practice reality. Pharmacy (Basel). 2018;6:124. doi:10.3990/pharmacy6040124

48.

Adams

AJ.

Advancing technician practice: deliberations of a regulatory board. Res Social Adm Pharm. 2018;14:1-5. doi:10.1016/j.sapharm.2017.02.008

49.

Rhode Island Code. 216-RICR-40-15-1. Title 216—Department of Health. Chapter 40—Professional licensing and facility regulation. Subchapter 15—Pharmacy. Accessed July 4, 2020. https://risos-apa-production-public.s3.amazonaws.com/DOH/REG_9974_20181011091351.pdf

50.

Tsuyuki

Houle

SKD

Okada

Time to give up on expanded scope of practice. Can Pharm J (Ott). 2018;151: 286-287. doi:10.2177/1715163518793844

51.

Broughel

Yatsyshina

Relax pharmacy regulations to help with COVID-19 testing and treatment. Published March 27, 2020. Accessed July 26, 2020. https://www.mercatus.org/system/files/broughel_and_yatsyshina_-_policy_brief_-_covid_series_-_what_covid-19_means_for_the_practice_of_pharmacy_-_v1_1.pdf